Related Experiment Video
Updated: Sep 19, 2026

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice
Published on: March 2, 2019
Human inborn errors of the phagocyte respiratory burst: Chronic granulomatous disease and beyond
Anna-Lena Neehus1,2,3,4, Vijay G Sankaran1,2,3,4,5, Jean-Laurent Casanova6,7,8,9,10,11,12
1Division of Hematology & Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract:
The phagocyte respiratory burst is an effector mechanism of immunity by which granulocytes, monocytes, and other myeloid cells generate reactive oxygen species (ROS). Inborn errors of core phagocyte NADPH oxidase components (gp91phox, p22phox, p47phox, and p67phox) underlie most cases of chronic granulomatous disease, characterized by severe, recurrent bacterial and fungal infections. An expanding spectrum of inborn errors of immunity (IEIs) has been identified that affect molecules that trigger (IFN-γ, TNF, and their signaling pathways) or control NADPH oxidase assembly and activation (EROS, p40phox, PKCδ, RAC2, and DOCK2), thereby impairing ROS production. Studies of these genetic disorders, which include infection, autoinflammation, and autoimmunity, have identified crucial pathways governing the induction, regulation, assembly, priming, activation, and function of the phagocyte NADPH oxidase complex. We review here the diverse IEIs affecting phagocyte ROS production, highlighting disorders in which ROS generation is absent, reduced, or subset-specific, and the corresponding cellular, immunological, and clinical phenotypes.
Related Concept Videos
Tuberculosis
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Microbiota of the Respiratory Tract
Chronic Inflammation: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

